China Investment News

Visit China Venture News

HD Biosciences Raises First Round

Posted on August 16, 2008

PE HUB is reporting that HD Biosciences Inc. of Shanghai has raised an undisclosed amount of Series A funding. HD Bio is a biology contract research group. Morningside Venture and Lilly Asian Ventures led the round together. Pfizer Venture Investments was also involved in the funding. We are pleased to have such an outstanding group of investors supporting the ongoing effort to build a world-class biology CRO serving the pharmaceutical and biotechnology industries, said Xuehai Tan, Ph.D., president and chief executive officer of HD Biosciences. As chemistry outsourcing increasingly shifts to...

Original article link


china , shanghai